LINICAL CHEMISTRY CALIBRATION VERIFIERS LEVELS A - E FOR BECKMAN COULTER SYNCHRON SYSTEMS
K031921 · Cliniqa Corporation · JJY · Aug 25, 2003 · Clinical Chemistry
Device Facts
| Record ID | K031921 |
| Device Name | LINICAL CHEMISTRY CALIBRATION VERIFIERS LEVELS A - E FOR BECKMAN COULTER SYNCHRON SYSTEMS |
| Applicant | Cliniqa Corporation |
| Product Code | JJY · Clinical Chemistry |
| Decision Date | Aug 25, 2003 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 862.1660 |
| Device Class | Class 1 |
Intended Use
LiniCAL™ Chemistry Calibration Verifiers Levels A - E for Beckman Coulter Synchron® Systems is intended for use as an assayed quality control material for analysis.
Device Story
LiniCAL™ Chemistry Calibration Verifiers are assayed quality control materials used to verify the calibration and linearity of clinical chemistry assays on Beckman Coulter Synchron® Systems. The device consists of five levels (A-E) of liquid-stable, human-serum based materials. It is used by laboratory professionals in clinical settings to monitor instrument performance and ensure the accuracy of patient test results. By comparing measured values of the verifiers against expected values, clinicians can confirm that the analytical measurement range of the instrument is properly calibrated.
Clinical Evidence
No clinical data provided; bench testing only.
Technological Characteristics
Liquid-stable, human-serum based quality control material. Provided in five levels (A-E). Designed for use with Beckman Coulter Synchron® chemistry analyzers. No specific materials or software algorithms described.
Indications for Use
Indicated for use as an assayed quality control material for analysis on Beckman Coulter Synchron® Systems.
Regulatory Classification
Identification
A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.
Related Devices
- K030150 — LINICAL PROTEIN 5 CALIBRATION VERIFIERS LEVELS A-E FOR BECKMAN COULTER ARRAY AND IMMAGE PROTEIN SYSTEMS · Cliniqa Corporation · Jan 28, 2003
- K023250 — LINICAL PROTEIN 2 CALIBRATION VERIFIERS LEVELS A-E FOR THE BECKMAN-COULTER IMMAGE · Cliniqa Corporation · Oct 17, 2002
- K013332 — LINICAL PROTEIN I CALIBRATION VERIFIERS LEVELS A=E FOR BECKMAN COULTER IMMAGE · Cliniqa Corporation · Nov 20, 2001
- K022885 — LINICAL PROTEIN 4 CALIBRATION VERIFIERS LEVELS-A-E FOR BECKMAN COULTER IMMAGE · Cliniqa Corporation · Oct 2, 2002
- K110880 — VALIDATE (R) GC3 CALIBRATION VERIFICATION / LINEARITY TEST KIT · Maine Standards Company, LLC · Jul 5, 2011
Submission Summary (Full Text)
{0}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/0/Picture/1 description: The image shows a black and white logo. The logo consists of a symbol with three stylized, curved lines that resemble a person with outstretched arms. The symbol is surrounded by text arranged in a circular pattern. The text is small and difficult to read, but it appears to be the name of an organization or agency.
Public Health Service
AUG 2 5 2003
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
Ms. Carol Ruggiero Director of Regulatory Affairs CLINIOA Corporation 1432 South Mission Road Fallbrook, CA 92028
k031921 Re:
Trade/Device Name: LiniCAL™ Chemistry Calibration Verifiers Levels A - E for Beckman Coulter Synchron® Systems Regulation Number: 21 CFR 862.1660 Regulation Name: Quality Control Material (Assayed and Unassayed) Regulatory Class: Class I Product Code: JJY Dated: June 13, 2003 Received: June 27, 2003
Dear Ms. Ruggiero:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
{1}------------------------------------------------
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific information about the application of labeling requirements to your device. or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 594-3084. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Steven Sutman
Steven I. Gutman, M.D., M.B.A. Director Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
510(k) Number (if known):
Device Name: LiniCAL™ Chemistry Calibration Verifiers Levels A - E for Beckman Coulter Synchron® Systems
Indications For Use:
LiniCAL™ Chemistry Calibration Verifiers Levels A - E for Beckman Coulter Synchron® Systems is intended for use as an assayed quality control material for analysis.
Alberts Sut
Division Sign-Off for Joan Cooper
Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) k 031921
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
OR
Over-The-Counter Use